Canadian Halal Investor.

NYSE Shariah screener · October 2026

Is Kenvue Inc. (KVUE) Halal?

PASS

Kenvue Inc. · NYSE: KVUE · Consumer Staples

The short answer

Yes — Kenvue (KVUE) passes this Shariah stock screen. Its business is consumer health and personal care (Tylenol, Band-Aid, Neutrogena, Listerine, Aveeno; spun off from Johnson & Johnson in 2023) with no prohibited lines. Interest-bearing debt of about $8.48B ($7,074M long-term debt + $1,406M loans and notes payable, per the Q2 2026 Form 10-Q) is about 24.7% of its ~$34.4B market cap (Finnhub, October 2026), below the ~33% ceiling. Interest income of $24M is about 0.31% of first-half 2026 net sales ($7,864M), well under the 5% non-compliant income ceiling. Zoya and ShariaPortfolio both rate KVUE Shariah-compliant; no Musaffa coverage was found.

Gate 1 — Business activity: PASS

Kenvue Inc. (NYSE: KVUE) is the world's largest pure-play consumer health company by revenue, separated from Johnson & Johnson in 2023. It is organized into three segments — Self Care (Tylenol, Motrin, Zyrtec, Benadryl, Nicorette), Skin Health and Beauty (Neutrogena, Aveeno, Clean & Clear), and Essential Health (Listerine, Band-Aid, Johnson's). None of the disclosed lines — over-the-counter medicines, skin and beauty care, oral care, wound care, and baby care — are prohibited lines (no alcohol, gambling, pork, conventional banking/insurance, tobacco, cannabis, or adult entertainment). Gate 1 passes. Facts only.

Gate 2 — Debt and cash: PASS

At June 28, 2026 Kenvue's interest-bearing debt was about $8.48B — long-term debt of $7,074M plus loans and notes payable of $1,406M, per the Q2 2026 Form 10-Q condensed consolidated balance sheet (the company also reported total debt of $8.5B in its Q2 2026 results release). Against a market cap of about $34.4B (Finnhub quote, October 2026), debt ÷ market cap is about 24.65%, below the ~33% ceiling. Cash and cash equivalents of $1,110M are about 3.2% of market cap, within the ~33% guideline. Gate 2 passes. Facts only.

Gate 3 — Non-compliant income: PASS

Interest income was $24M for the fiscal six months ended June 28, 2026 ($13M in Q2), disclosed as a separate line in the Notes to Condensed Consolidated Financial Statements in the Q2 2026 Form 10-Q, against net sales of $7,864M — about 0.31% of revenue, well below the 5% non-compliant income limit. Interest expense for the half was $209M (interest expense, net $185M). Gate 3 passes. Facts only.

Key figures used

Frequently asked questions

What does Kenvue do?

Kenvue Inc. (NYSE: KVUE) is a global consumer health company spun off from Johnson & Johnson in 2023. Its portfolio spans over-the-counter medicines, skin health and beauty, essential health, and baby and family care, with widely recognized brands including Tylenol, Band-Aid, Neutrogena, Listerine, Aveeno, Johnson's, Zyrtec, Motrin, and Nicorette. It reports in three segments: Self Care, Skin Health and Beauty, and Essential Health. It is headquartered in Summit, New Jersey.

Why does Kenvue pass this Shariah stock screen?

Kenvue passes all three gates of this Shariah stock screen. Its business is consumer health and personal care, with no disclosed alcohol, gambling, pork, tobacco, conventional banking or insurance, or other prohibited lines, so the business gate passes. Interest-bearing debt of about $8.48B is about 24.7% of its ~$34.4B market cap, below the ~33% ceiling, so the financial-structure gate passes. Interest income of $24M is about 0.31% of first-half 2026 net sales of $7,864M, well below the 5% non-compliant income ceiling, so the income gate passes. This is a factual screen, not a religious ruling — consult a qualified scholar for personal guidance.

What is Kenvue's interest-bearing debt ratio?

At June 28, 2026, Kenvue's interest-bearing debt was about $8.48B — long-term debt of $7,074M plus loans and notes payable of $1,406M (per the Q2 2026 Form 10-Q balance sheet; the company also reported total debt of $8.5B in its Q2 2026 results release). Against a market capitalization of about $34.4B (Finnhub quote, October 2026), debt ÷ market cap is about 24.65%, below the ~33% ceiling. Cash and cash equivalents of $1,110M are about 3.2% of market cap, also within the ~33% guideline. The financial-structure gate passes.

What is Kenvue's non-compliant income ratio?

For the fiscal six months ended June 28, 2026, Kenvue disclosed interest income of $24M (with $13M in Q2 alone) in the notes to its Q2 2026 Form 10-Q, against net sales of $7,864M — about 0.31% of revenue, well below the 5% non-compliant income ceiling. Interest expense for the half was $209M, giving interest expense, net of $185M. The income gate passes.

Do Zoya, Musaffa, or ShariaPortfolio cover Kenvue?

Zoya covers KVUE and lists it as Shariah-compliant as of October 2026 (zoya.finance/stocks/kvue). ShariaPortfolio also covers KVUE and lists it as Shariah compliant, passing all 5 of the standards it screens against. No coverage of KVUE on Musaffa was found — honestly reported as absent, not invented. This page applies the screen directly from the company's filings: the Q2 2026 Form 10-Q for the quarter ended June 28, 2026 and the FY2025 Form 10-K (fiscal year ended December 28, 2025, filed February 20, 2026).

Sources

Screened 2026-10-02 from published company figures and market data. Figures change; this page is educational, not financial advice and not a religious ruling.

Screened with our two-gate Shariah screening methodology (business-activity gate, then AAOIFI-style financial ratios).